|Year : 2016 | Volume
| Issue : 4 | Page : 359-362
Cytology and histopathology of an unusual neck mass: Extraskeletal myxoid chondrosarcoma
Pooja Chauhan, Neelam Sharma, Lalita Negi, Sudershan Kumar Sharma
Department of Pathology, Indira Gandhi Medical College, Shimla, Himachal Pradesh, India
|Date of Web Publication||12-Jul-2016|
H. No 51, Housing Board Colony, Sanyard, P.O. Talyahar, Mandi - 175 001, Himachal Pradesh
Source of Support: None, Conflict of Interest: None
Extraskeletal myxoid chondrosarcomas (EMCs) are rare soft tissue tumors with estimated incidence of 2.3% among all soft tissue sarcomas. Most of these tumors occur in the extremities with only a few cases reported in the head and neck region. Histologically, these tumors exhibit a broad spectrum of morphologic features, which make distinction from other neoplasms difficult, particularly when the tumor occurs at an unusual anatomic location. We present a case report of a 55-year-old male with colloid goiter who presented with a recent increase in his long-standing anterior neck swelling. A computed tomography scan demonstrated a cartilaginous lesion in the soft tissue of the neck. Subsequent cytological and histological examination revealed EMC.
Keywords: Chondromyxoid stroma, extraskeletal myxoid chondrosarcomas, neck mass
|How to cite this article:|
Chauhan P, Sharma N, Negi L, Sharma SK. Cytology and histopathology of an unusual neck mass: Extraskeletal myxoid chondrosarcoma. Clin Cancer Investig J 2016;5:359-62
|How to cite this URL:|
Chauhan P, Sharma N, Negi L, Sharma SK. Cytology and histopathology of an unusual neck mass: Extraskeletal myxoid chondrosarcoma. Clin Cancer Investig J [serial online] 2016 [cited 2020 Nov 26];5:359-62. Available from: https://www.ccij-online.org/text.asp?2016/5/4/359/186106
| Introduction|| |
Extraskeletal myxoid chondrosarcoma (EMCs), initially recognized by Stout and Verner in 1953, is a rare soft tissue malignancy. It was defined as a distinct clinicopathologic entity by Enzinger and Shiraki in 1972 and was called chordoid sarcoma because it resembles chordoma histologically. However, because of the close resemblance of the tumor cells to developing chondroblasts, electron microscopic data suggested that EMCs originates in the primitive cartilage-forming mesenchyme. The tumor has since been called EMC.
EMCs is most commonly located in the deep soft tissues of the lower extremity and the buttock. The present example of EMCs arose in the soft tissue of the neck, a very unusual primary location for this tumor. EMCs behave in a less aggressive manner than do other forms of chondrosarcomas, but their clinical course can vary considerably. Surgery is main-stay treatment; adjuvant radiotherapy or chemotherapy should be considered for cases displaying more cellular pattern and a less conspicuous myxoid matrix.
| Case Report|| |
A 55-year-old male migratory laborer from ambient iodine deficiency zone of Nepal  visited the outpatient department with the chief complaint of sudden increase in anterior neck swelling for 1 year associated with progressive dysphagia, dyspnea, stridor, and hoarseness of voice. History of presenting illness revealed that the neck swelling was present for 14 years and diagnosed previously as colloid goiter by fine-needle aspiration cytology (FNAC).
General physical examination was remarkable for increased jugular venous pressure and enlarged cervical lymph nodes. A firm, irregular, nontender swelling was observed in the anterior neck more to the right side. Overlying skin was normal with prominent jugular veins [Figure 1]. Thyroid function test, complete hemogram, and biochemical tests were within normal limits. Contrast-enhanced computerized tomography of neck and chest showed 12 cm × 10 cm × 8 cm heterogeneous mass in the soft tissue of neck extending from the angle of the mandible to superior mediastinum internally. It invaded the thyroid cartilage with encasement of brachiocephalic trunk. The patient was referred to our department for FNAC and subsequently underwent incisional biopsy from the neck mass.
FNA showed cellular smears comprised of abundant chondromyxoid stroma with cells present singly and in cords. Tumor cells appearing to be in lacunae had round to oval grooved hyperchromatic nuclei and eosinophilic cytoplasm [Figure 2] and [Figure 3]. The possibility of EMCs was suggested. Subsequent incisional biopsy revealed multiple lobules separated by fibrous septa with areas of chondroid differentiation. The individual tumor lobule consisted of the round to slightly elongated tumor cells having mild pleomorphism, hyperchromatic nuclei, and deeply eosinophilic cytoplasm set in a myxoid stroma [Figure 4] and [Figure 5]. The diagnosis of EMCs on histopathology supported the cytological diagnosis.
|Figure 2: Low power view showing cellular smears with abundant chondromyxoid stroma|
Click here to view
|Figure 4: Low-power view of an extraskeletal myxoid chondrosarcoma with a characteristic nodular arrangement|
Click here to view
|Figure 5: High-power view of tumour cells in extraskeletal myxoid chondrosarcoma|
Click here to view
| Discussion|| |
EMCs is an unusual soft tissue sarcoma with ultrastructural and molecular features distinct from that of skeletal myxoid chondrosarcoma. EMCs typically affects patients in the fifth and sixth decade of life; however, cases have been reported in children. This tumor arises principally in the proximal extremities and limb girdles. However, occurrences in synovium, pleura, maxillary sinus, epiglottis, soft tissue of the chin, and retroperitoneum have been reported.
Diagnostic cytomorphologic criteria for EMCs have been described in the literature among few case reports and small case series. Common features include a background myxoid matrix with embedded tumor cells, anastomosing cords and lace-like arrangements or clusters of the uniform round to spindle-shaped cells with bland appearing nuclei and inconspicuous nucleoli, and grooved or cleaved nuclei suggesting chondroblast-like derivation; all of which were identified in our case. Other cell types have been reported to occur but only in rare cases, including epithelioid cells with vesicular nuclei, prominent nucleoli, and abundant cytoplasm.
On histological examination, EMC has a multinodular pattern consisting of round or slightly elongated cells of uniform shape and size, in short anastomosing cords or strands, and less frequently in small, loose aggregates set in variable amounts of mucoid material. The individual cells have small hyperchromatic nuclei and a narrow rim of deeply eosinophilic cytoplasm, features characteristic of chondroblasts. Unlike chondrosarcoma of bone, differentiated cartilage cells with distinct lacunae are rare.
EMCs may be difficult to distinguish from a number of benign or malignant chondroid-like or myxoid lesions. EMCs may easily be misdiagnosed as the myxoid variant of some other soft tissue sarcomas. Pathological considerations in the differential diagnosis of EMCs should include chondromyxoid fibroma, juxtacortical (parosteal) chondrosarcomas, chordoma, and myxoid liposarcoma, as well as predominantly myxoid lesions such as aggressive angiomyxoma, low-grade myxofibrosarcoma, and low-grade fibromyxoid sarcoma.
The t(9;22)(q22;q12) translocation appears to be pathognomonic for EMC and has not been found in other mesenchymal tumors. In terms of immunohistochemistry, the tumor cells are positive to vimentin. The expression of S-100, the epithelial membrane antigen and neurofilament have been found to be inconstantly positive while synaptophysin positivity has also been reported.
These low-grade sarcomas have an estimated 10-year survival of 70%, 48% local recurrence and 46% metastases. Metastatic lesions spread hematogenously, with a predilection for the lungs.
The treatment of patients with localized EMCs should include excision of the primary tumor with a wide surgical margin. EMCs have been reported to respond to high-dose radiation while being poorly responsive to adjuvant chemotherapy. When a wide margin cannot be obtained, the benefits of marginal surgery with adjuvant radiation must be weighed against the risk of recurrent disease, given the relative resistance of this tumor to radiation therapy. Amputation should be considered more strongly in such patients. However, in our case surgery was deemed impossible because of extensive tissue involvement. Furthermore, patient, a migratory laborer was lost to follow-up.
| Conclusion|| |
EMC itself is a rare sarcoma with predilection for the limbs but may present with diagnostic challenge when present in unusual anatomic location. Detection of the EWS-CHN gene fusion resulting from the t(9;22) is a helpful diagnostic tool because it is positive in at least 75% of cases. Even more rarely it may originate in the region of the neck. The only satisfactory chance of cure of these tumors is early diagnosis and surgical intervention in patients with the localized disease and long-term follow-up.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Sotomayor E, Sarma D, Xiao S. Extraskeletal myxoid chondrosarcoma of oropharynx. Internet J Pathol 2006;6:4.
Ganguly R, Mukherjee A. Maxillo-facial extraskeletal myxoid chondrosarcoma: A case report and discussion. Korean J Pathol 2011;45:639-43.
Mavrogenis AF, Patapis P, Papaparaskeva KT, Galanis EC, Papagelopoulos PJ. Extraskeletal myxoid chondrosarcoma of the perineum. Orthopedics 2009;32:216.
Antonescu CR, Argani P, Erlandson RA, Healey JH, Ladanyi M, Huvos AG. Skeletal and extraskeletal myxoid chondrosarcoma: A comparative clinicopathologic, ultrastructural, and molecular study. Cancer 1998;83:1504-21.
Liu-Shindo M, Rice DH, Sherrod AE. Extraskeletal myxoid chondrosarcoma of the head and neck: A case report. Otolaryngol Head Neck Surg 1989;101:485-8.
Pandav CS. IDD in Southeast Asia. In: Hetzel BS, Pandav CS, editors. SOS for a Billion, the Conquest of Iodine Deficiency Disorders. Delhi: Oxford University Press; 1994. p. 213-31.
Hisaoka M, Hashimoto H. Extraskeletal myxoid chondrosarcoma: Updated clinicopathological and molecular genetic characteristics. Pathol Int 2005;55:453-63.
Weiss SW, Goldblum JR, editors. Extraskeletal myxoid chondrosarcoma. In: Enzinger and Weiss's Soft Tissue Tumors. 4th
ed. Philadelphia, PA: Mosby; 2001. p. 1368-79.
Orejudos MP, Hutton RL, Hilton JO. Extraskeletal myxoid chondrosarcoma: A case report with cytologic features, histopathology, and variant translocation. J Cytol Histol 2012;3:146.
Stenman G, Andersson H, Mandahl N, Meis-Kindblom JM, Kindblom LG. Translocation t(9;22)(q22;q12) is a primary cytogenetic abnormality in extraskeletal myxoid chondrosarcoma. Int J Cancer 1995;62:398-402.
O'Brien J, Thornton J, Cawley D, Farrell M, Keohane K, Kaar G, et al.
Extraskeletal myxoid chondrosarcoma of the cerebellopontine angle presenting during pregnancy. Br J Neurosurg 2008;22:429-32.
Oliveira AM, Sebo TJ, McGrory JE, Gaffey TA, Rock MG, Nascimento AG. Extraskeletal myxoid chondrosarcoma: A clinicopathologic, immunohistochemical, and ploidy analysis of 23 cases. Mod Pathol 2000;13:900-8.
Gebhardt MC, Parekh SG, Rosenberg AE, Rosenthal DI. Extraskeletal myxoid chondrosarcoma of the knee. Skeletal Radiol 1999;28:354-8.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]